Preventing Early Renal Loss in Diabetes (PERL) study: A randomized double-blinded trial of allopurinoldrationale, design, and baseline data
Maryam Afkarian, Sarit Polsky, Afshin Parsa, Ronnie Aronson, Maria Luiza Caramori, David Z. Cherney, Jill P. Crandall, Ian H. De Boer, Thomas G. Elliott, Andrzej T. Galecki, Allison B. Goldfine, J. Sonya Haw, Irl B. Hirsch, Amy B. Karger, Ildiko Lingvay, David M. Maahs, Janet B. McGill, Mark E. Molitch, Bruce A. Perkins, Rodica Pop-BusuiMarlon Pragnell, Sylvia E. Rosas, Peter Rossing, Peter Senior, Ronald J. Sigal, Catherine Spino, Katherine R. Tuttle, Guillermo E. Umpierrez, Amisha Wallia, Ruth S. Weinstock, Chunyi Wu, Michael Mauer, Alessandro Doria*, PERL Study Group
Dive into the research topics of 'Preventing Early Renal Loss in Diabetes (PERL) study: A randomized double-blinded trial of allopurinoldrationale, design, and baseline data'. Together they form a unique fingerprint.